Jeffrey Stein - 21 Feb 2023 Form 4 Insider Report for Paratek Pharmaceuticals, Inc.

Role
Director
Signature
/s/ William M. Haskel, Attorney-in-Fact for Jeffrey Stein
Issuer symbol
N/A
Transactions as of
21 Feb 2023
Net transactions value
-$13,300
Form type
4
Filing time
23 Feb 2023, 13:27:11 UTC
Previous filing
09 Feb 2023
Next filing
27 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRTK Common Stock Sale $13,300 -7,000 -9.3% $1.90 68,625 21 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units, pursuant to a Rule 10b5-1 trading plan.